Adenovirus type 4 a

Ended Awarded

Contract number
SPE2DP26F6516
Awardee
Awarding agency
Obligated
$343,526

Award facts

Contract value 100% obligated
$343,526.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency Medical Supply Chain issued a $343,526.40 delivery order to Teva Pharmaceuticals Usa, Inc. on June 16, 2026, for Adenovirus Type 4 vaccine, with an ultimate completion date of June 23, 2026.

The order is firm fixed price with place of performance in Parsippany, NJ. The source does not name a parent IDV vehicle for this delivery order; based on Teva's federal contracting history, the award likely falls under the Defense Logistics Agency Troop Support Medical's Adenovirus Type 4 vaccine indefinite delivery contract (SPE2DP20D0002), under which Teva holds 559 prior delivery orders totaling $665.9 million in combined potential value. No set-aside was used.

Quick answers

Who was awarded contract SPE2DP26F6516?

SPE2DP26F6516 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on June 16, 2026.

How much is contract SPE2DP26F6516 worth?

The government has obligated $343,526 on SPE2DP26F6516.

Is contract SPE2DP26F6516 an order under another contract?

Yes. SPE2DP26F6516 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP26F6516 competed?

The extent of competition for SPE2DP26F6516 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award